Login / Signup

Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials.

Alberto Cordero-FortJulio NuñezVicente Bertomeu-GonzálezLorenzo FácilaMª Amparo QuintanillaMoisés Rodríguez-MañeroDavid EscribanoAlfonso ValleRafael de la EspriellaJavier Torres-LlergoAntoni Bayés-GenísJosé R González-Juanatey
Published in: American journal of therapeutics (2022)
Keyphrases
  • heart failure
  • clinical trial
  • cardiovascular events
  • risk factors
  • ejection fraction
  • atrial fibrillation
  • phase ii
  • cardiovascular disease
  • type diabetes
  • acute heart failure
  • coronary artery disease